276 related articles for article (PubMed ID: 26349954)
21. Publication patterns of cancer cost-effectiveness studies presented at major conferences.
Chan KK; Siu E; Mozessohn L; Cheung MC
Curr Oncol; 2013 Dec; 20(6):319-25. PubMed ID: 24311947
[TBL] [Abstract][Full Text] [Related]
22. Authorship characteristics of hematology and oncology education chapters: A comprehensive analysis.
Altarawneh H; Manasrah M; Al Shanableh Y; Saed Aldien A; Manasrah MA; Khan S; Altarawneh L; Al-Kraimeen LM; Al Kasaji F; Alareeki A; Al Hadidi S
J Cancer Policy; 2024 Jun; 40():100484. PubMed ID: 38750724
[TBL] [Abstract][Full Text] [Related]
23. Increasing family medicine scholarly presentations and the incidence of duplicate research abstracts.
Weaver SP; Lastrapes E
Fam Med; 2014 Jun; 46(6):467-9. PubMed ID: 24911304
[TBL] [Abstract][Full Text] [Related]
24. Discrepancies and rates of publication in orthopaedic sports medicine abstracts.
Kleweno CP; Bryant WK; Jacir AM; Levine WN; Ahmad CS
Am J Sports Med; 2008 Oct; 36(10):1875-9. PubMed ID: 18667625
[TBL] [Abstract][Full Text] [Related]
25. The fate of research abstracts submitted to a national surgical conference: a cross-sectional study to assess scientific impact.
de Meijer VE; Knops SP; van Dongen JA; Eyck BM; Vles WJ
Am J Surg; 2016 Jan; 211(1):166-71. PubMed ID: 26349584
[TBL] [Abstract][Full Text] [Related]
26. The ASH/ASCO clinical guidelines on the use of erythropoietin.
Lichtin A
Best Pract Res Clin Haematol; 2005; 18(3):433-8. PubMed ID: 15792917
[TBL] [Abstract][Full Text] [Related]
27. Contributions to the American Society of Hematology Meeting From Low- and Middle-Income Countries: An In-Depth Analysis and Call to Action.
Gómez-De León A; Colunga-Pedraza PR; Tarín-Arzaga L; Bugarín-Estrada E; Sung L; Cantú-Martínez O; Jaime-Pérez JC; Gómez-Almaguer D
JCO Glob Oncol; 2021 Apr; 7():622-631. PubMed ID: 33909458
[TBL] [Abstract][Full Text] [Related]
28. Are presentations of abstracts at EGPRN meetings followed by publication?
Van Royen P; Sandholzer H; Griffiths F; Lionis C; Rethans JJ; Galí F; Eilat-Tsanani S; Hummers-Pradier E
Eur J Gen Pract; 2010 Jun; 16(2):100-5. PubMed ID: 20504264
[TBL] [Abstract][Full Text] [Related]
29. American Society of Clinical Oncology 41st annual meeting.
Dillman RO
Expert Opin Biol Ther; 2005 Aug; 5(8):1117-27. PubMed ID: 16050788
[TBL] [Abstract][Full Text] [Related]
30. Publication rates of scientific presentations at the American Association of Hip and Knee Surgeons annual meetings from 1996 to 2001.
Lloyd EW; Geller JA; Iorio R; Yoon RS; Huo M; Macaulay W
J Arthroplasty; 2006 Sep; 21(6 Suppl 2):2-5. PubMed ID: 16950054
[TBL] [Abstract][Full Text] [Related]
31. Subjects presented at ASHP Midyear Clinical Meetings, 1967-90.
Pearson RE; Allan EL
Am J Hosp Pharm; 1994 Jul; 51(14):1788-92. PubMed ID: 7942907
[TBL] [Abstract][Full Text] [Related]
32. High-profile studies frequently and repetitively present data on the same patients, particularly in immunotherapy studies.
Ellis-Caleo T; Lisberg A; Tucker DA; Garon EB
J Thorac Dis; 2018 Feb; 10(Suppl 3):S397-S403. PubMed ID: 29593885
[TBL] [Abstract][Full Text] [Related]
33. Financial conflicts of interest in economic analyses in oncology.
Jang S; Chae YK; Majhail NS
Am J Clin Oncol; 2011 Oct; 34(5):524-8. PubMed ID: 21441858
[TBL] [Abstract][Full Text] [Related]
34. Improving the quality of abstract reporting for phase I cancer trials.
Strevel EL; Chau NG; Pond GR; Murgo AJ; Ivy PS; Siu LL
Clin Cancer Res; 2008 Mar; 14(6):1782-7. PubMed ID: 18347180
[TBL] [Abstract][Full Text] [Related]
35. Presentation and publication rates among women and men at AAO-HNS meetings.
Cohen MA; Mirza N; Dow K; Abboud SK
ORL J Otorhinolaryngol Relat Spec; 2012; 74(6):325-9. PubMed ID: 23295356
[TBL] [Abstract][Full Text] [Related]
36. Use of subjective minimizing language at hematology and oncology conferences: A systematic review.
Abusamak AA; Abusamak M; Al-Abbadi M; Rayyan A; Oran O; Mohyuddin GR; Kelkar AH; Goodman AM; Chakraborty R; Cliff ERS; Al Hadidi S
J Cancer Policy; 2024 Mar; 39():100461. PubMed ID: 38061494
[TBL] [Abstract][Full Text] [Related]
37. ASCO Plenary Sessions: impact, legacy, future.
Vandross A; Prasad V; Mailankody S
Semin Oncol; 2016 Jun; 43(3):321-6. PubMed ID: 27178681
[TBL] [Abstract][Full Text] [Related]
38. [Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].
Vignot S; André T; Gonçalves A; Guièze R; Magné N; Orbach D; Penel N; Thariat J; Wislez M; Bay JO
Bull Cancer; 2017 Jan; 104(1):6-19. PubMed ID: 28007296
[TBL] [Abstract][Full Text] [Related]
39. Frequency and determinants of nonpublication of research in the stroke literature.
Sanossian N; Ohanian AG; Saver JL; Kim LI; Ovbiagele B
Stroke; 2006 Oct; 37(10):2588-92. PubMed ID: 16931779
[TBL] [Abstract][Full Text] [Related]
40. [The impact of the annual scientific meetings of the Israel Society of Rheumatology as measured by publication rates of the abstracts in peer-reviewed journals].
Perez S; Hashkes PJ; Uziel Y
Harefuah; 2004 Apr; 143(4):266-9, 319. PubMed ID: 15116582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
